The interactive maps and charts below are updated daily to track the progress ... the agency says. So far, yes. Pfizer-BioNTech’s booster—the only one currently authorized in the U.S ...

Vaccine availability is on a first-come, first-served basis and while supplies last. Updated bivalent Pfizer-BioNTech and Moderna COVID-19 vaccines and boosters will be available at the clinics. The ...

A new study shows that immunity after a COVID-19 booster lasts much longer than the primary series alone. These findings are among other, sometimes 'unintuitive,' revelations of how factors like age, ...

BioNTech's long-term outlook helped it shrug off a first-quarter loss and sinking revenue as demand for COVID-19 vaccines ...

Pfizer-BioNTech, Moderna, Sanofi/GSK and Novavax. Those getting the spring booster will be given an mRNA vaccine made by either Pfizer or Moderna. Both have been updated to help protect against ...

Germany's BioNTech , whose COVID-19 vaccine in partnership with Pfizer was widely used during the pandemic, said on Monday ...

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the ...

3 Numbers include effects identified from additional collaborations or potential M&A transactions to the extent disclosed and are subject to update ... BioNTech and Pfizer developed, manufactured ...

The change was mainly due to recognizing lower cost of sales from BioNTech’s decreased COVID-19 vaccine sales, which included the share of gross profit that BioNTech owes its ...